FindTrial
Sign In

B3GAT1 Exacerbates Cisplatin-Induced Neurotoxicity and Enhances Anti-Tumor Efficacy by Upregulating Neutrophils: A Retrospective Study.

B3GAT1 Exacerbates Cisplatin-Induced Neurotoxicity and Enhances Anti-Tumor Efficacy by Upregulating Neutrophils: A Retrospective Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128113
Enrollment
Unknown
Registered
2026-07-14
Start date
2025-08-01
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Cancer ? Neurotoxicity

Interventions

Observation group:none

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Diagnosis of an advanced malignant tumor; 2.Initial diagnosis at age >=18 years; 3.Pathological confirmation via biopsy at Sun Yat-sen University Cancer Center; 4.History of immunotherapy;

Exclusion criteria

Exclusion criteria: 1.Did not meet the inclusion criteria;

Design outcomes

Primary

MeasureTime frame
Neurotoxicity;—

Countries

China

Contacts

Public ContactZhao Hongyun

Sun Yat-sen University Cancer Center

zhaohy@sysucc.org.cn+86 20 87342482

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026